Lorbrexen (Lorlatinib) 100 MG – 30 Tablets


Lorbrexen (Lorlatinib) is a potent, brain-penetrant, third-generation inhibitor of ALK and ROS1 tyrosine kinases with broad coverage of ALK mutations. In a phase 1 study, activity was seen in patients with ALK-positive non-small-cell lung cancer, most of whom had CNS metastases and progression after ALK-directed therapy.

Whatsapp +8801922101029